Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure

Annals of Pharmacotherapy

Volumn 39, Issue 5, 2005, Pages 953-955

  Christie, Megan J ^a,b   Wong, Karen ^b   Ting, Robert H ^b,c   Tam, Paul Y ^c,d   Sikaneta, Tabo Gordon ^b,c,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b SCARBOROUGH HOSPITAL   (Canada)

^c Nephrology Associates   (Canada)

^d SCARBOROUGH HOSPITAL   (United Kingdom)

^e Department of Medicine ^*  (Canada)

Author keywords

Fluoroquinolones; Levofloxacin; Seizure; Toxic epidermal necrolysis

Indexed keywords

CIPROFLOXACIN; GRAMICIDIN; LEVOFLOXACIN; MAGNESIUM; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AGED; ANAMNESIS; ARTICLE; BLISTER; BRAIN RADIOGRAPHY; CASE REPORT; CLINICAL FEATURE; DRUG EXPOSURE; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; FEMALE; GRAND MAL SEIZURE; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAGNESIUM BLOOD LEVEL; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PRURITUS; RASH; SKIN BIOPSY; TONIC CLONIC SEIZURE; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS, URINARY; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; OFLOXACIN; SEIZURES;

EID: 17644386868     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E587     Document Type: Article

References (12)

1. Lipsky BA, Baker CA. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis 1999;28:352-64.
2. Carbon C. Comparison of side effects of levofloxacin versus other fluoroquinolones. Chemotherapy 2001;47(suppl 3):9-14.
3. Kushner JM, Peckman HJ, Snyder CR. Seizures associated with fluoroquinolones. Ann Pharmacother 2001;35:1194-8. DOI 10.1345/aph.10359
4. Stalnikowicz R. The significance of routine serum magnesium determination in the ED. Am J Emerg Med 2003;21:444-7. DOI 10.1016/S0735-6757(03)00097-4
5. Turnbull TL, Vanden Hoek TL, Howes DS, Eisner RF. Utility of laboratory studies in the emergency department patient with a new-onset seizure. Ann Emerg Med 1990;19:373-7.
6. Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Saf 2002;25:91-110.
7. Schmuck G, Schurmann A, Schluter G. Determination of the excitatory potencies of fluoroquinolones in the central nervous system by in an vitro model. Antimicrob Agents Chemother 1998;42:1831-6.
8. Digwood-Lettieri S, Reilly KJ, Haith LR, Patton ML, Guilday RJ, Cawley MJ, et al. Levofloxacin-induced toxic epidermal necrolysis in an elderly patient. Pharmacotherapy 2002;22:789-93.
9. Livasy CA, Kaplan AM. Ciprofloxacin-induced toxic epidermal necrolysis: a case report. Dermatology 1995;195:173-5.
10. Wehrli P, Viard I, Bullani R, Tschopp J, French LE. Death receptors in cutaneous biology and disease. J Invest Derm 2000;115:141-8.
11. Moshfeghi M, Mandler HD. Ciprofloxacin-induced toxic epidermal necrolysis. Ann Pharmacother 1993;27:1467-9.
12. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.